ASH ITP Guidelines: Changes in the Role of Thrombopoietin Agonist, Treatment Scheme and Major Changes in the Guidelines
Upon viewing this session, you will be able to:
• Recognize rationale for the differences between the 2011 and 2019 guidelines.
• Explain new recommendations for upfront therapy in adult ITP.
• Describe the major changes in recommendations around second line management of adult ITP.
• Increase comfort level in managing all phases and severity of ITP.